Home > Insider Trading > Filing (0001209191-15-046303)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1469443	Arcadia Biosciences Inc.	RKDA	Agricultural Chemicals (2870)	810571538

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1641250	Uday Garg	C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-05-20	375,000	$8.00	375,000	No	4	P	Indirect	By Mandala Capital AG Limited
Common Stock	Acquisiton	2015-05-20	8,705,808	$0.00	9,080,808	No	4	C	Indirect	By Mandala Agribusiness Co-Investments I Limited

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Mandala Capital AG Limited
No	4	C	Indirect	By Mandala Agribusiness Co-Investments I Limited

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D Convertible Preferred Stock	Disposition	2015-05-20	8,918,750	$0.00	8,705,808	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Mr. Garg is a member of the board of directors of Mandala Agribusiness Fund, which exercises shared voting and investment power over the shares owned by Mandala Agribusiness Co-Investments I Limited. Mr. Garg disclaims beneficial ownership of all securities listed herein, except to the extent of his pecuniary interest therein.
The Series D Convertible Preferred Stock converted into the Issuer's common stock at a conversion ratio of one share of common stock for approximately every 1.0245 shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. This conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015.